Aliskiren



Indications and Reactions:

Role Indications Reactions
Primary
Hypertension 34.8%
Cardiac Failure 17.1%
Cardiac Failure Chronic 9.1%
Cardiovascular Disorder 8.4%
Diabetes Mellitus 7.2%
Coronary Artery Disease 3.1%
Type 2 Diabetes Mellitus 2.6%
Hyperlipidaemia 2.2%
Prophylaxis 2.1%
Hyperuricaemia 2.1%
Atrial Fibrillation 2.0%
Cardiac Failure Congestive 1.7%
Thrombosis Prophylaxis 1.5%
Cardiac Failure Acute 1.0%
Chronic Obstructive Pulmonary Disease 0.9%
Gastritis Prophylaxis 0.9%
Hypercholesterolaemia 0.9%
Insomnia 0.8%
Benign Prostatic Hyperplasia 0.8%
Nephrotic Syndrome 0.8%
Death 15.1%
Cardiac Failure 10.2%
Renal Impairment 9.9%
Urine Albumin/creatinine Ratio Increased 7.7%
Renal Failure 5.1%
Syncope 4.8%
Renal Failure Chronic 4.5%
Hyponatraemia 3.7%
Renal Failure Acute 3.7%
Vomiting 3.7%
Weight Decreased 3.7%
Coronary Artery Disease 3.4%
Glycosylated Haemoglobin Increased 3.4%
Blood Creatinine Increased 3.1%
Blood Pressure Increased 3.1%
Dyspnoea 3.1%
Hyperkalaemia 3.1%
Sudden Cardiac Death 3.1%
Glomerular Filtration Rate Decreased 2.8%
Angina Pectoris 2.6%
Secondary
Cardiac Failure 45.2%
Hypertension 13.3%
Cardiac Failure Chronic 8.4%
Diabetes Mellitus 4.1%
Coronary Artery Disease 3.6%
Cardiovascular Disorder 3.4%
Cardiac Failure Congestive 3.0%
Hyperuricaemia 2.7%
Prophylaxis 2.6%
Type 2 Diabetes Mellitus 2.3%
Atrial Fibrillation 1.8%
Insomnia 1.5%
Hyperlipidaemia 1.4%
Glaucoma 1.3%
Thrombosis Prophylaxis 1.1%
Myocardial Infarction 1.1%
Renal Failure Chronic 0.8%
Dyslipidaemia 0.8%
Hypokalaemia 0.8%
Product Used For Unknown Indication 0.8%
Renal Impairment 10.2%
Vomiting 9.2%
Dyspnoea 7.6%
Prostate Cancer 6.7%
Cardiac Failure 6.1%
Concomitant Disease Progression 5.4%
Hypotension 5.1%
Syncope 5.1%
Vertigo 5.1%
Weight Increased 4.8%
Disease Progression 4.1%
Renal Failure 4.1%
Pulmonary Oedema 3.8%
Asthma 3.5%
Condition Aggravated 3.5%
Ventricular Tachycardia 3.5%
Death 3.2%
Urinary Tract Infection 3.2%
General Physical Health Deterioration 2.9%
Hyperkalaemia 2.9%
Concomitant
Drug Use For Unknown Indication 30.3%
Hypertension 19.7%
Product Used For Unknown Indication 18.7%
Diabetes Mellitus 4.1%
Blood Pressure 3.4%
Pain 3.0%
Atrial Fibrillation 2.6%
Rheumatoid Arthritis 2.4%
Gastrooesophageal Reflux Disease 1.7%
Blood Cholesterol Increased 1.5%
Arthritis 1.5%
Chronic Sinusitis 1.5%
Type 2 Diabetes Mellitus 1.5%
Prostate Cancer Metastatic 1.3%
Supplementation Therapy 1.3%
Asthma 1.2%
Depression 1.2%
Cardiac Disorder 1.1%
Glioblastoma 1.1%
Hyperlipidaemia 1.1%
Renal Failure 10.8%
Rhabdomyolysis 7.5%
Drug Ineffective 5.8%
Pneumonia 5.8%
Weight Decreased 5.8%
Weight Increased 5.8%
Blood Glucose Increased 5.0%
Hyperkalaemia 5.0%
Pruritus 5.0%
Thrombocytopenia 5.0%
Cardiac Failure Acute 4.2%
Death 4.2%
Dyspnoea 4.2%
Hypotension 4.2%
Stevens-johnson Syndrome 4.2%
Suicide Attempt 4.2%
Cardiac Failure 3.3%
Cerebrovascular Accident 3.3%
Dizziness 3.3%
Myalgia 3.3%
Interacting
Hypertension 73.3%
Otitis Media Acute 10.0%
Pain 6.7%
Cardiac Failure Chronic 3.3%
Infection 3.3%
Product Used For Unknown Indication 3.3%
Nausea 33.3%
Peripheral Coldness 33.3%
Electrocardiogram Qrs Complex Prolonged 11.1%
Heart Rate Increased 11.1%
Tachycardia 11.1%